Dyne Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
JANUS HENDERSON GROUP PLC | 05/15/2025 | 10.35 M | $118.47 M | 40.30% | 9.42% |
RA CAPITAL MANAGEMENT, L.P. | 05/15/2025 | 9.71 M | $101.61 M | 52.24% | 8.84% |
ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC | 05/14/2025 | 9.13 M | $95.50 M | 13.86% | 8.31% |
BLACKROCK, INC. | 05/02/2025 | 8.05 M | $84.17 M | 1.23% | 7.32% |
VANGUARD GROUP INC | 05/09/2025 | 7.41 M | $77.47 M | 10.48% | 6.74% |
FCPM III SERVICES B.V. | 05/15/2025 | 5.46 M | $57.14 M | 0.00% | 4.97% |
FMR LLC | 05/12/2025 | 5.20 M | $54.34 M | -35.03% | 4.73% |
BRAIDWELL LP | 05/15/2025 | 3.62 M | $37.88 M | 431.63% | 3.29% |
STATE STREET CORP | 05/15/2025 | 3.61 M | $37.76 M | -2.90% | 3.28% |
CITADEL ADVISORS LLC | 05/15/2025 | 3.01 M | $31.48 M | 5.17% | 2.74% |
ARMISTICE CAPITAL, LLC | 05/15/2025 | 2.77 M | $28.95 M | 186.98% | 2.52% |
SIREN, L.L.C. | 05/23/2025 | 2.72 M | $28.43 M | 101.71% | 2.47% |
TCG CROSSOVER MANAGEMENT, LLC | 05/14/2025 | 2.65 M | $27.72 M | 0.00% | 2.41% |
JPMORGAN CHASE & CO | 05/12/2025 | 2.53 M | $26.48 M | 2,472.81% | 2.30% |
PERCEPTIVE ADVISORS LLC | 08/06/2025 | 2.31 M | $24.20 M | 325.82% | 2.10% |
VR ADVISER, LLC | 05/15/2025 | 2.17 M | $22.74 M | 0.00% | 1.98% |
DEEP TRACK CAPITAL, LP | 05/15/2025 | 2.00 M | $20.92 M | 0.00% | 1.82% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 1.96 M | $20.46 M | 3.61% | 1.78% |
PRICE T ROWE ASSOCIATES INC /MD/ | 05/14/2025 | 1.82 M | $19.04 M | -24.23% | 1.66% |
VESTAL POINT CAPITAL, LP | 05/15/2025 | 1.80 M | $18.83 M | 100.00% | 1.64% |
RTW INVESTMENTS, LP | 05/15/2025 | 1.69 M | $17.68 M | -67.61% | 1.54% |
POINT72 ASSET MANAGEMENT, L.P. | 07/21/2025 | 1.53 M | $15.99 M | 65.30% | 1.39% |
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 05/15/2025 | 1.44 M | $15.10 M | 100.00% | 1.31% |
FRANKLIN RESOURCES INC | 05/13/2025 | 1.41 M | $14.80 M | 6.88% | 1.29% |
MORGAN STANLEY | 05/15/2025 | 1.39 M | $14.56 M | 84.66% | 1.27% |
VOLORIDGE INVESTMENT MANAGEMENT, LLC | 05/15/2025 | 1.39 M | $14.52 M | 1,066.60% | 1.26% |
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 05/14/2025 | 1.17 M | $12.22 M | 100.00% | 1.06% |
VIVO CAPITAL, LLC | 05/12/2025 | 1.11 M | $11.66 M | 0.00% | 1.01% |
ORBIMED ADVISORS LLC | 05/15/2025 | 1.01 M | $10.61 M | -17.32% | 0.92% |
GOLDMAN SACHS GROUP INC | 06/27/2025 | 994.89 K | $10.41 M | 58.24% | 0.91% |
ARROWMARK COLORADO HOLDINGS LLC | 05/15/2025 | 897.95 K | $9.39 M | -3.68% | 0.82% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 05/15/2025 | 812.41 K | $8.50 M | 86.48% | 0.74% |
NORTHERN TRUST CORP | 05/13/2025 | 722.46 K | $7.56 M | -7.02% | 0.66% |
SOFINNOVA INVESTMENTS, INC. | 05/15/2025 | 716.90 K | $7.50 M | -33.09% | 0.65% |
MPM ASSET MANAGEMENT LLC | 05/15/2025 | 682.38 K | $7.14 M | 0.00% | 0.62% |
QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2025 | 680.84 K | $7.12 M | 154.64% | 0.62% |
BAKER BROS. ADVISORS LP | 05/15/2025 | 672.10 K | $7.03 M | 0.00% | 0.61% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 654.13 K | $6.84 M | -2.00% | 0.60% |
WOODLINE PARTNERS LP | 05/15/2025 | 574.44 K | $6.01 M | 0.08% | 0.52% |
ROCK SPRINGS CAPITAL MANAGEMENT LP | 05/15/2025 | 524.50 K | $5.49 M | 10.53% | 0.48% |
WASATCH ADVISORS LP | 05/15/2025 | 511.05 K | $5.35 M | 59.39% | 0.47% |
LOGOS GLOBAL MANAGEMENT LP | 05/15/2025 | 500.00 K | $5.23 M | 11.11% | 0.45% |
ALGERT GLOBAL LLC | 05/13/2025 | 476.01 K | $4.98 M | 488.22% | 0.43% |
CANDRIAM S.C.A. | 05/14/2025 | 463.37 K | $4.85 M | 15.44% | 0.42% |
INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 05/15/2025 | 450.00 K | $4.71 M | 200.00% | 0.41% |
SG AMERICAS SECURITIES, LLC | 04/15/2025 | 430.05 K | $4.50 M | 2,159.15% | 0.39% |
IKARIAN CAPITAL, LLC | 05/15/2025 | 358.84 K | $3.75 M | 100.00% | 0.33% |
UBS GROUP AG | 05/13/2025 | 357.75 K | $3.74 M | -33.76% | 0.33% |
NANTAHALA CAPITAL MANAGEMENT, LLC | 05/15/2025 | 345.06 K | $3.61 M | 100.00% | 0.31% |
TREXQUANT INVESTMENT LP | 05/14/2025 | 334.44 K | $3.50 M | 166.75% | 0.30% |
Dyne Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 181 institutional investors and hedge funds held shares of Dyne Therapeutics, Inc.. The most heavily invested institutionals were:
Stephens Consulting, LLC: 0
DIMENSIONAL FUND ADVISORS LP: 0
FOX RUN MANAGEMENT, L.L.C.: 0
Handelsbanken Fonder AB: 0
Larson Financial Group LLC: 0
Corebridge Financial, Inc.: 0
110.86% of Dyne Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 96.51 M shares in the last 24 months. This purchase volume represents approximately $1.18 B in transactions.